Tuberculosis test kits order

NewsGuard 100/100 Score

Medical Services International Inc.has announced that it has received its first order for the VScan Tuberculosis (TB) rapid test kit from a prominent pharmaceutical company that produces Tuberculosis vaccines.

The kits will be used immediately in conjunction with their testing and treatment programs that have been set up in India. The Company is offering a complete program that includes testing and treatment of TB in their own facilities situated throughout India.

The requirements for the VScan TB test kit could be as high as 50,000 kits in the initial program. If the program is successful the initial program will be expanded and the requirement for the VScan TB kit will increase significantly.

Three million people die from TB every year. TB kills more adults than ALL other infectious diseases combined. Eight million new TB cases are diagnosed each year. The VScan TB test kit is the only test available that does not give false positives.

No other TB test kit is as accurate as the VScan TB rapid test kit. Of the 2 billion people infected with TB, 200 million worldwide will develop active TB and then be able to infect others. The key to controlling the spread of TB is accurate and fast diagnosis so that treatment can begin. About VScan The VScan rapid test kit is a single use, easy to use test for the screening of HIV 1&2 subgroup O, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile.

For further information http://www.medicalservicesintl.com .

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO releases an investment case for TB screening and preventive treatment